Literature DB >> 31831499

Adrienne Lindblad1, Stacy Jardine2, Michael R Kolber3.   

Abstract

Year:  2019        PMID: 31831499      PMCID: PMC6907371     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


× No keyword cloud information.
  13 in total

Review 1.  Onychomycosis in the 21st Century: An Update on Diagnosis, Epidemiology, and Treatment.

Authors:  Aditya K Gupta; Sarah G Versteeg; Neil H Shear
Journal:  J Cutan Med Surg       Date:  2017-06-22       Impact factor: 2.092

Review 2.  Oral antifungal medication for toenail onychomycosis.

Authors:  Sanne Kreijkamp-Kaspers; Kate Hawke; Linda Guo; George Kerin; Sally Em Bell-Syer; Parker Magin; Sophie V Bell-Syer; Mieke L van Driel
Journal:  Cochrane Database Syst Rev       Date:  2017-07-14

3.  British Association of Dermatologists' guidelines for the management of onychomycosis 2014.

Authors:  M Ameen; J T Lear; V Madan; M F Mohd Mustapa; M Richardson
Journal:  Br J Dermatol       Date:  2014-11       Impact factor: 9.302

Review 4.  Toenail Onychomycosis-A Canadian Approach With a New Transungual Treatment: Development of a Clinical Pathway.

Authors:  Aditya K Gupta; R Gary Sibbald; Anneke Andriessen; Richard Belley; Alan Boroditsky; Mariam Botros; Robert Chelin; Wayne Gulliver; David Keast; Mani Raman
Journal:  J Cutan Med Surg       Date:  2015-04-09       Impact factor: 2.092

5.  Double blind, randomised study of continuous terbinafine compared with intermittent itraconazole in treatment of toenail onychomycosis. The LION Study Group.

Authors:  E G Evans; B Sigurgeirsson
Journal:  BMJ       Date:  1999-04-17

6.  Cost-effectiveness of Confirmatory Testing Before Treatment of Onychomycosis.

Authors:  Anar Mikailov; Jeffrey Cohen; Cara Joyce; Arash Mostaghimi
Journal:  JAMA Dermatol       Date:  2016-03       Impact factor: 10.282

7.  Long-term results in patients with onychomycosis treated with terbinafine or itraconazole.

Authors:  H Heikkilä; S Stubb
Journal:  Br J Dermatol       Date:  2002-02       Impact factor: 9.302

8.  Efinaconazole solution in the treatment of toenail onychomycosis: a phase 2, multicenter, randomized, double-blind study.

Authors:  Eduardo H Tschen; Alicia D Bucko; Norihide Oizumi; Hideki Kawabata; Jason T Olin; Radhakrishnan Pillai
Journal:  J Drugs Dermatol       Date:  2013-02       Impact factor: 2.114

9.  Oral terbinafine in the treatment of toenail onychomycosis: North American multicenter trial.

Authors:  L A Drake; N H Shear; J P Arlette; R Cloutier; F W Danby; B E Elewski; S Garnis-Jones; J M Giroux; D Gratton; W Gulliver; P Hull; H E Jones; M Journet; A L Krol; J J Leyden; S C Maddin; J B Ross; R C Savin; R K Scher; G R Sibbald; N H Tawfik; N Zaias; M Tolpin; S Evans; J E Birnbaum
Journal:  J Am Acad Dermatol       Date:  1997-11       Impact factor: 11.527

10.  An innovative water-soluble biopolymer improves efficacy of ciclopirox nail lacquer in the management of onychomycosis.

Authors:  R Baran; A Tosti; I Hartmane; P Altmeyer; J Hercogova; V Koudelkova; T Ruzicka; P Combemale; I Mikazans
Journal:  J Eur Acad Dermatol Venereol       Date:  2009-05-04       Impact factor: 6.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.